Navigation Links
Bypass surgery improves survival for patients with diabetes and multi-vessel coronary artery disease
Date:11/5/2012

(Toronto Nov. 4, 2012) An international, clinical research trial has shown that patients with diabetes whose multi-vessel coronary artery disease is treated with bypass surgery live longer and are less likely to suffer severe complications like heart attacks than those who undergo angioplasty.

The findings are published online today in The New England Journal of Medicine (10.1056/NEJMoa1211585). The study co-led by researchers at New York's Mount Sinai Hospital and Toronto's Peter Munk Cardiac Centre, University Health Network (UHN) is known as the FREEDOM trial.

"We've shown that bypass surgery saves one extra life for every 20 patients with diabetes who are treated for multi-vessel coronary artery disease," says lead author, Dr. Michael Farkouh, Chair of the Peter Munk Centre of Excellence in Multinational Clinical Trials, Peter Munk Cardiac Centre, UHN.

Five years after treatment, patients who received coronary artery bypass grafts (CABG) had lower combined rates of strokes, heart attacks, and deaths (18.7 percent) than those who underwent angioplasty (26.6 percent). Strokes were slightly more common among the CABG group (5.2 percent) than in the angioplasty group (2.4 percent), however, more angioplasty patients died from any cause (16.3 percent) than CABG patients (10.9 percent).

"Based on these results, we believe that coronary artery bypass surgery should be standard therapy for the millions of patients worldwide with diabetes who have more than one diseased vessel," says Dr. Farkouh, who is the Chair of Cardiology Research and an associate professor of medicine at the University of Toronto.

Coronary artery disease is the buildup of plaque in the coronary arteries. It's the most common form of heart disease and can lead to chest pain, heart failure and heart attack. According to the Public Health Agency of Canada, almost 2.4 million Canadians live with diabetes.1

A total of 1,900 patients were enrolled at 140 international centers from 2005-2010. All participants had diabetes and more than one diseased artery, and 83% had three-vessel disease. Half the participants received bypass surgery and the other group received angioplasty which includes percutaneous coronary intervention and drug-eluting stents. The study followed patients for a median of four years and a minimum of two. Patients in both streams of the study were prescribed optimal medical management for control of high LDL cholesterol, high blood sugar levels and high blood pressure. The result assessed all-cause mortality, non-fatal heart attacks, and non-fatal stroke.

"This study will challenge the prevailing ambiguity between bypass surgery and angioplasty for multi-vessel coronary artery disease," says Dr. Farkouh. "Bypass surgery saves lives and reduces the chance of complications in a high-risk group of patients with diabetes."

The study focused on diabetes because patients with diabetes have cardiac events more often than patients who do not have diabetes, and require more follow-up care than other patients. Cardiovascular disease is a major complication of diabetes and the leading cause of early death among people with this disease about 65 percent of people with diabetes die from heart disease and stroke. Adults with diabetes are two to four times more likely to have heart disease or suffer a stroke than people without diabetes.

"The benefits of bypass surgery are so significant that they're what you'd expect to see between a patient who is and a patient who isn't taking medication to control cholesterol," says Dr. Farkouh.


'/>"/>

Contact: Geoff Koehler
geoff.koehler@uhn.ca
416-340-4800 x3417
University Health Network
Source:Eurekalert

Related medicine news :

1. Bypass Beats Stents for Diabetic Heart Patients: Study
2. Cardiac bypass surgery superior to non-surgical procedure for adults with diabetes and heart disease
3. Stroke Risk Higher After Bypass Than Angioplasty: Analysis
4. Less Invasive Surgery Safe for Harvesting Bypass Veins: Study
5. Lab-Grown Blood Vessels May Improve Heart Bypass
6. Moveable Magnets Used to Forge Gastric Bypass in Pigs
7. When considering bariatric surgery think about bones
8. Stereotactic radiosurgery shows promise for kidney cancer
9. Radiation treatment after surgery improves survival for elderly women with early-stage breast cancer
10. Mothers Weight-Loss Surgery Linked to Kids Heart Health
11. Progress in ultrasound-guided surgery may improve breast cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... ... announced its latest release of SentinelSecure™, version 3.0, will be available in a ... This newest version of SentinelSecure™ comes with several new enhancements including support for ...
(Date:9/25/2017)... ... September 25, 2017 , ... FDAnews Expert Insight Series:, Device ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/deviceregulation      , FDA Commissioner ... four short months:, ,     The first device recall over cybersecurity ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... The award ... in helping those with disabilities. Each year the award is given to those who ... with disabilities live their best lives in communities of their choosing. Recent recipients of ...
(Date:9/25/2017)... ... September 25, 2017 , ... Just ask anyone old enough to remember what ... headgear so wired up and containing so much metal that jokes about radio reception ... its treatments can barely be observed. As a result, it’s now a billion-dollar industry ...
(Date:9/25/2017)... Lancaster, California (PRWEB) , ... September 25, 2017 ... ... like to announce the launch of its new website. No need to ... WDD has the answer. Go to welldonedesigns.com where all orders are printed and ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017  Robert G. Szewc, M.D., ... Professional Member in recognition of his contributions to the ... as a Nephrologist at the practice of Kidney and ... kidney care and hypertension solutions. He has worked in ... of career experience, as well as expertise in kidneys, ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
(Date:9/5/2017)... 2017  Xyntek Inc. has announced another milestone in their continued growth and ... meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 West Adams Street, Suite 1528, ... Xyntek's recently ... ...
Breaking Medicine Technology: